thiophenes has been researched along with Aortic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, A; Wang, J; Zhao, M; Zhu, H | 1 |
| Bäck, M; Brink, C; Foudi, N; Louedec, L; Michel, JB; Norel, X; Rienzo, M | 1 |
| Belmadani, S; Boulares, AH; Datta, R; Fallon, K; Hans, CP; Naura, A; Oumouna-Benachour, K; Suzuki, Y; Woods, C | 1 |
3 other study(ies) available for thiophenes and Aortic Diseases
| Article | Year |
|---|---|
AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antigens, Ly; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biphenyl Compounds; Cell Line; Cell Migration Inhibition; Chemotaxis; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Genetic Predisposition to Disease; Humans; Macrophages; Metformin; Mice, Knockout; Phenotype; Pyrones; Receptors, CCR2; Ribonucleotides; Signal Transduction; Thiophenes | 2017 |
Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Cholesterol; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Epoprostenol; Hypercholesterolemia; Indomethacin; Male; Norepinephrine; Rabbits; Thiophenes; Vasoconstriction; Vasoconstrictor Agents | 2009 |
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Topics: Active Transport, Cell Nucleus; Animals; Aortic Diseases; Apolipoproteins E; Apoptosis; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Cholesterol; Collagen; Crosses, Genetic; Diet, Atherogenic; Drug Evaluation, Preclinical; Foam Cells; Gene Expression Regulation; Genotype; Hydrogen Peroxide; Hypercholesterolemia; Hypertriglyceridemia; Isoquinolines; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; NF-kappa B; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Specific Pathogen-Free Organisms; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Triglycerides | 2007 |